Detalhe da pesquisa
1.
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Ann Oncol
; 34(8): 714-722, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182801
2.
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Ann Oncol
; 34(3): 262-274, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535565
3.
[Immunotherapy in head and neck squamous cell carcinoma : Abscopal effects in combination with radiotherapy, extraordinary responses in combination with chemotherapy, and pseudoprogression]. / Immuntherapie bei Kopf-Hals-Plattenepithelkarzinomen : Abskopale Effekte in Kombination mit Radiotherapie, außergewöhnliche Reaktionen in Kombination mit Chemotherapie und Pseudoprogression.
Internist (Berl)
; 61(7): 682-689, 2020 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-32462252
4.
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.
Ann Oncol
; 30(2): 297-302, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30481287
5.
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
Ann Oncol
; 30(1): 68-75, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407504
6.
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.
Ann Oncol
; 27(5): 908-13, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26884588
7.
Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Ann Oncol
; 26(1): 198-205, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361984
8.
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
Ann Oncol
; 26(6): 1216-1223, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712460
9.
A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck.
Ann Oncol
; 25(9): 1813-1820, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24928832
10.
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.
Ann Oncol
; 30(10): 1673, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168601
11.
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Ann Oncol
; 24(3): 769-76, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23104721
12.
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Ann Oncol
; 22(10): 2304-9, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21330337
13.
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Ann Oncol
; 22(11): 2501-2507, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21385883
14.
Accurate HPV testing: a requirement for precision medicine for head and neck cancer.
Ann Oncol
; 24(11): 2711-3, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24170608
15.
Spreading depression induces permanent cell swelling under penumbra conditions.
Acta Neurochir Suppl
; 76: 251-5, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11450018
16.
Modelling of the ischemic penumbra.
Acta Neurochir Suppl
; 73: 41-4, 1999.
Artigo
em Inglês
| MEDLINE | ID: mdl-10494339
17.
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA.
Oral Oncol
; 49(6): 525-33, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23490885
18.
State-of-the-art management of locally advanced head and neck cancer.
Br J Cancer
; 92(8): 1341-8, 2005 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15846296